MwanzoPSTV • NASDAQ
add
Plus Therapeutics Inc
$ 0.25
Baada ya Saa za Kazi:(3.80%)+0.0095
$ 0.26
Imefungwa: 17 Mac, 18:05:11 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 0.26
Bei za siku
$ 0.25 - $ 0.26
Bei za mwaka
$ 0.16 - $ 2.08
Thamani ya kampuni katika soko
43.00M USD
Wastani wa hisa zilizouzwa
5.60M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.37M | -3.19% |
Matumizi ya uendeshaji wa biashara | 4.17M | 33.33% |
Mapato halisi | -5.71M | -46.37% |
Kiwango cha faida halisi | -417.92 | -51.19% |
Mapato kwa kila hisa | 0.00 | 100.00% |
EBITDA | -5.60M | -57.57% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 8.61M | 138.82% |
Jumla ya mali | 16.32M | 146.12% |
Jumla ya dhima | 12.33M | -20.88% |
Jumla ya hisa | 4.00M | — |
hisa zilizosalia | 171.55M | — |
Uwiano wa bei na thamani | 8.69 | — |
Faida inayotokana na mali | -82.04% | — |
Faida inayotokana mtaji | -176.22% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -5.71M | -46.37% |
Pesa kutokana na shughuli | -6.26M | -416.68% |
Pesa kutokana na uwekezaji | -1.08M | -1,782.81% |
Pesa kutokana na ufadhili | 2.80M | — |
Mabadiliko halisi ya pesa taslimu | -4.53M | -295.03% |
Mtiririko huru wa pesa | -4.01M | -1,221.55% |
Kuhusu
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
Ilianzishwa
1996
Makao Makuu
Tovuti
Wafanyakazi
21
